Jubilant Pharmova
JUBLPHARMA.NS
#4308
Rank
ยฃ1.57 B
Marketcap
ยฃ9.95
Share price
-2.77%
Change (1 day)
103.51%
Change (1 year)

Revenue for Jubilant Pharmova (JUBLPHARMA.NS)

Revenue in 2024 (TTM): ยฃ0.64 Billion

According to Jubilant Pharmova's latest financial reports the company's current revenue (TTM ) is ยฃ0.65 Billion. In 2023 the company made a revenue of ยฃ0.62 Billion a decrease over the revenue in the year 2022 that were of ยฃ0.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jubilant Pharmova from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.64 B2.99%
2023 ยฃ0.62 B-1.11%
2022 ยฃ0.62 B3.36%
2021 ยฃ0.60 B-7.92%
2020 ยฃ0.66 B-26.32%
2019 ยฃ0.89 B-11.39%
2018 ยฃ1.01 B30.84%
2017 ยฃ0.77 B11.65%
2016 ยฃ0.69 B16.31%
2015 ยฃ0.59 B-2.17%
2014 ยฃ0.60 B7.64%
2013 ยฃ0.56 B